Table of Content

Chapter 1 Executive Summary
Chapter 2 Scope and Research Methodology
Chapter 3 Molecular Diagnostics – Changing-Industry Dynamics
3.1. Increasing market penetration of molecular diagnostics in precision medicine industry
3.2. Increasing demand for molecular diagnostics in emerging markets due to advancement in molecular techniques and diagnostics test
Chapter 4 Latest Organic and Inorganic Developments in Molecular Diagnostics in Healthcare
Inorganic Developments mentioned in this report are: Acquisitions, Mergers, Investments,
Funding and Collaboration
Chapter 5 FDA Rules and Regulations Restraining Factors in Molecular Diagnostics
Chapter 6 Molecular Diagnostics for Applications: Infectious Disease, Oncology, Genetic Testing, Blood
Screening
Chapter 7 Molecular Diagnostics Technology Analysis
7.1. Fast and inexpensive polymerase chain reaction (PCR) technology used to amplify
small segments of DNA
7.2. Fluorescence in situ hybridization (FISH) a laboratory technique for detecting and locating
a specific DNA sequence on a chromosome
7.3. Sequencing (DNA & NGS) including genomics, proteomics, transcriptomics, metabolomics
7.4. Microarray technology used for genotyping and determination of disease-relevant
genes or agents causing diseases
7.5. Isothermal Nucleic Acid Amplification Technology (INAAT) high on demand especially for
Clinical application
7.6. Other technologies includes: Electrophoresis, Mass spectroscopy and Flow cytometry
Chapter 8 Competition Assessment:-
Competitive Landscape in Molecular Diagnostics-
8.1. Molecular Diagnostics Market share analysis by Products & Services offered by the Leading
Companies
8.2. Region wise market share analysis of Molecular Diagnostics Market
8.3. Latest Technologies offered by the competitors in Molecular Diagnostics Market
8.4. Latest Developments such as partnerships, collaboration, mergers & acquisitions, funding by
the competitors in molecular Diagnostics market
8.5. Leading Players in Molecular Diagnostics Market mentioned in report-
Roche Diagnostics, Qiagen, Becton Dickinson (BD), Abbott Laboratories, Hologic
(includes Gen-Probe), Agilent Technologies, Cepheid, Siemens Healthcare,
BioM?rieux, Quest Diagnostics Incorporated

Chapter 9 Appendix
9.1. References
9.2. Excerpt of interviews with leading industry players